U.S. Commercial Services Stock News

Why Southern Copper is on investors’ radar today Southern Copper (SCCO) has drawn attention after recent trading left the stock with a 1 day return of 1.4% and a past month move of about a 25% decline, sharpening focus on its valuation. See our latest analysis for Southern Copper. The recent pullback in Southern Copper’s share price, with a 30 day return of about a 25% decline, contrasts with its 1 year total shareholder return of 83.6%. This suggests longer term momentum, while short term...

First Bancorp (FBNC) has drawn fresh attention after recent share price moves, with the stock now trading at US$55.19. That price corresponds to a year total return of 39.5% for investors. See our latest analysis for First Bancorp. The recent pullback, with a 1-month share price return of an 8.34% decline, sits against a stronger backdrop of an 8.41% year to date share price return and a 39.55% 1-year total shareholder return. This suggests momentum has cooled, but long-term holders have...

Earlier this year, ManpowerGroup reported quarterly revenue growth of 7.1% year on year, beating analyst expectations but missing EPS estimates, while highlighting progress in cost optimization, technology initiatives, and a disciplined transformation plan amid gradually stabilizing market trends. A separate initiative, the 2026 VivaTech Startup Challenge, underscores how ManpowerGroup is using AI to address talent shortages, with its latest survey showing employer demand for AI capabilities...

Recent softness in Nutanix (NTNX) billings and quarterly results has hit sentiment hard, even as the company rolls out AI focused offerings and new security partnerships that speak to longer term product ambitions. See our latest analysis for Nutanix. The share price has been under pressure, with a 1 day share price return showing a 4.66% decline and a 90 day share price return showing a 28.82% decline. The 3 year total shareholder return of 44.71% contrasts sharply with the 1 year total...

SANUWAVE Health (SNWV) closed out FY 2025 with Q4 revenue of US$13.1 million and basic EPS of US$0.71, while trailing 12 month figures show revenue of US$44.1 million and basic EPS of US$1.38 as the company moved to positive earnings over the period. Over recent quarters, revenue has ranged from US$9.3 million in Q1 2025 to US$13.1 million in Q4 2025, with basic EPS swinging from a loss of US$0.66 per share to a gain of US$1.20 in Q3 2025 and US$0.71 in Q4 2025. This sets up a cleaner...

EDS Service Solutions has already expanded its airport operations with Avis Budget Group across four major Texas markets, launching services at San Antonio International and Austin-Bergstrom in March, followed by Dallas-Fort Worth International and Dallas Love Field in April. This broader workforce partnership strengthens Avis Budget Group’s operational support in high-traffic airport rental locations, potentially improving service consistency and capacity at some of its busiest US...

D-Wave Quantum (NYSE:QBTS) announced a new interview podcast series, "Quantum Matters". The series will highlight real world quantum applications across industries such as manufacturing, supply chain, aerospace, life sciences and AI. The podcast will feature conversations with sector leaders focused on practical use cases for quantum computing. D-Wave Quantum operates in the quantum computing space, with a focus on practical problem solving for businesses rather than purely academic...

Rigetti Computing board member H. Gail Sandford has informed the company that she will not stand for re election at the upcoming annual meeting. The company has stated that Sandford’s decision is not due to any disagreement with Rigetti Computing on operations, policies, or practices. Her departure will create a vacancy on the board, which may be filled through future director appointments or changes in committee roles. For investors tracking NasdaqCM:RGTI, this board change comes at a time...

Legence (LGN) has just posted another busy quarter, with Q3 FY 2025 revenue of US$708.0 million and a small loss, as Basic EPS landed at a US$0.02 loss and net income excluding extra items was a US$1.1 million loss. The company has seen revenue move from US$560.8 million in Q3 FY 2024 to US$708.0 million in Q3 FY 2025. Over the trailing 12 months, revenue reached about US$2.4 billion against a trailing 12 month net loss of US$19.8 million, putting the spotlight squarely on scaling margins...

Murphy Oil (MUR) has drawn attention after a strong share price move, with returns around 34% over the past month and 35% in the past 3 months, prompting fresh interest in its valuation. See our latest analysis for Murphy Oil. The recent 33.7% 1 month share price return and 35.2% 3 month share price return sit alongside a 29.6% year to date share price return and 56.1% 1 year total shareholder return. Together, these figures point to strong momentum that could reflect shifting expectations...

FuboTV (FUBO) is back in focus after a 1-for-12 reverse stock split and a sharp share price drop, as weaker than expected earnings and ongoing cash burn unsettled many investors. See our latest analysis for FuboTV. The recent 1-for-12 reverse stock split and earnings miss have come against a weak backdrop, with a 7 day share price return of 31.57% decline and a 1 year total shareholder return of 73.33% loss. This points to fading momentum as concerns around cash burn grow. If this kind of...

ACM Research (ACMR) has been drawing attention after recent share price pressure, with the stock down 2.7% over the past day and 41.5% over the past month. That shift is prompting investors to revisit the company’s fundamentals. See our latest analysis for ACM Research. At the current share price of US$40.07, ACM Research’s short term share price return has been weak, with a 30 day share price decline of 41.5%. However, the 1 year total shareholder return of 62.8% and 3 year total shareholder...

Structure Therapeutics (NasdaqGM:GPCR) released highly positive Phase 2 topline data for its oral GLP-1 receptor agonist aleniglipron in obesity and overweight patients. The new results from the ACCESS clinical program show significant weight loss, a compelling safety and tolerability profile, and low discontinuation rates. The company plans to advance aleniglipron into Phase 3 trials based on these Phase 2 outcomes. Structure Therapeutics focuses on small molecule medicines, and...

Cboe Global Markets stock triggered by recent performance trends Cboe Global Markets (CBOE) has drawn fresh attention after recent share price moves, including a 2.4% decline over the past day and a 6.3% drop over the past month, despite a positive past 3 months return. See our latest analysis for Cboe Global Markets. While the recent 1 day and 1 month share price declines suggest some momentum is fading in the short term, the 10.03% year to date share price return and 23.97% 1 year total...

Wondering whether Dutch Bros at around US$46.69 still makes sense for your portfolio, or if the price now bakes in too much optimism. The stock has had a mixed run, with a 6.6% decline over the last week, an 8.2% decline over the past month, a 24.9% decline year to date, yet a 47.6% return over three years. Recent coverage has focused on how Dutch Bros fits into the broader consumer services space and how sentiment toward growth oriented concepts has shifted over time. This context helps...

Floor & Decor Holdings (FND) is expanding its warehouse store and design center footprint, with new openings in Syracuse, Bethel Park, and Grapevine that highlight ongoing store growth and fresh engagement with local customers and trade professionals. See our latest analysis for Floor & Decor Holdings. Despite the fresh store openings and local promotions, the share price has had a weak patch, with a 30 day share price return of a 26.62% decline and a 1 year total shareholder return of a...

Earlier this year, CSX announced a US$670 million agreement with Wabtec to upgrade its locomotive fleet with modern Evolution Series units, while partner TransloadX moved to revive two largely dormant Maine branch lines leased from CSX to support regional industrial rail activity. Together, these steps point to CSX pairing long-term efficiency upgrades in its core network with efforts to reactivate underused rail corridors through third-party investment. Next, we’ll examine how CSX’s US$670...

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...

If you are asking whether Target is priced fairly today, the starting point is understanding how the current share price lines up with different measures of value. The stock closed at US$119.84, with returns of 5.8% over 7 days, 2.9% over 30 days, 19.2% year to date, 20.9% over 1 year, and declines of 19.4% over 3 years and 31.0% over 5 years. Taken together, this gives you a mixed picture of both recent momentum and longer term risk. These moves sit against a backdrop where investors have...

Recent performance and what it might mean for TETRA Technologies (TTI) TETRA Technologies (TTI) has seen mixed share performance recently, with a 2.6% gain over the past day and 8.3% over the past week, compared with a decline of 22.6% over the past month and a 7.7% decline over the past three months. See our latest analysis for TETRA Technologies. Looking past the latest bounce, the 30 day share price return of negative 22.6% and year to date share price return of negative 11.95% sit against...

First Horizon (FHN) has drawn fresh attention after recent share moves, with the stock closing at US$22.13. For investors, that price invites a closer look at the bank’s fundamentals and current valuation. See our latest analysis for First Horizon. Over the past year, First Horizon’s 18.37% total shareholder return contrasts with a weaker recent patch, including a 30 day share price return of 9.64% decline. This suggests momentum has cooled even as longer term holders remain ahead. If First...

Event driven snapshot of Madrigal Pharmaceuticals Madrigal Pharmaceuticals (MDGL) has drawn investor attention after recent share price moves, including a 1 day return of about 2% and a 16% gain over the past week, against mixed month and past 3 months performance. See our latest analysis for Madrigal Pharmaceuticals. The recent 15.8% 7 day share price return contrasts with a weaker year to date share price performance and a much stronger 1 year total shareholder return of 55.8%. This...

Concentrix recently reported its first-quarter 2026 results, issued second-quarter and full-year guidance, confirmed a US$0.36 quarterly dividend for May 5, 2026, completed a large share repurchase program, and added Chih-Kai Cheng and Bilge Ogut to its board at the March 26 AGM. The combination of revenue growth alongside weaker earnings, expanding AI-focused offerings, ongoing capital returns, and refreshed board oversight highlights a business in the middle of a significant transformation...

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...